Year |
Citation |
Score |
2022 |
Guelen L, Fischmann TO, Wong J, Mauze S, Guadagnoli M, Bąbała N, Wagenaars J, Juan V, Rosen D, Prosise W, Habraken M, Lodewijks I, Gu D, Stammen-Vogelzangs J, Yu Y, ... ... Beebe AM, et al. Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy. Journal For Immunotherapy of Cancer. 10. PMID 36100308 DOI: 10.1136/jitc-2022-005049 |
0.411 |
|
2017 |
Sukumar S, Wilson DC, Yu Y, Wong J, Naravula S, Ermakov G, Riener R, Bhagwat B, Necheva AS, Grein J, Churakova T, Mangadu R, Georgiev P, Manfra D, Pinheiro EM, ... ... Beebe AM, et al. Characterization of MK-4166, a clinical agonistic antibody that targets human GITR and inhibits the generation and suppressive effects of T regulatory cells. Cancer Research. PMID 28611044 DOI: 10.1158/0008-5472.Can-16-1439 |
0.491 |
|
2016 |
Mahne A, Mauze S, Joyce-Shaikh B, Xia J, Bowman E, Beebe A, Cua D, Jain R. Dual roles for regulatory T cell depletion and co-stimulatory signaling in agonistic GITR targeting for tumor immunotherapy. Cancer Research. PMID 28122327 DOI: 10.1158/0008-5472.CAN-16-0797 |
0.367 |
|
2015 |
Brunn ND, Mauze S, Gu D, Wiswell D, Ueda R, Hodges D, Beebe AM, Zhang S, Escandon E. The Role of Anti-drug Antibodies in the Pharmacokinetics, Disposition, Target Engagement, and Efficacy of a GITR Agonist Monoclonal Antibody in Mice. The Journal of Pharmacology and Experimental Therapeutics. PMID 26669426 DOI: 10.1124/jpet.115.229864 |
0.458 |
|
2015 |
Ovacik AM, Shinsky-Bjorde N, Hodges D, Antonenko S, Ueda R, Mauze S, Gu D, Wiswell D, Zhang S, Beebe A, Tabrizi M. Abstract 4521: Evaluation of the relationship between serum exposure, receptor (GITR) availability and tumor suppression following administration of the anti-GITR antibody DX400 in mouse syngeneic tumor models Cancer Research. 75: 4521-4521. DOI: 10.1158/1538-7445.Am2015-4521 |
0.451 |
|
2014 |
Murphy JT, Burey AP, Beebe AM, Gu D, Presta LG, Merghoub T, Wolchok JD. Anaphylaxis caused by repetitive doses of a GITR agonist monoclonal antibody in mice Blood. 123: 2172-2180. PMID 24558202 DOI: 10.1182/Blood-2013-12-544742 |
0.414 |
|
2011 |
Mumm JB, Emmerich J, Zhang X, Chan I, Wu L, Mauze S, Blaisdell S, Basham B, Dai J, Grein J, Sheppard C, Hong K, Cutler C, Turner S, LaFace D, ... ... Beebe AM, et al. IL-10 elicits IFNγ-dependent tumor immune surveillance. Cancer Cell. 20: 781-96. PMID 22172723 DOI: 10.1016/j.ccr.2011.11.003 |
0.496 |
|
2002 |
Beebe AM, Cua DJ, de Waal Malefyt R. The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). Cytokine & Growth Factor Reviews. 13: 403-12. PMID 12220553 |
0.334 |
|
Show low-probability matches. |